In mouse models of cancers, reduced tumor growth in mice treated by anti-TNF drugs or in TNFR2 knockout mice was associated with decreased numbers of MDSCs suggesting that TNF increases survival, recruitment, or function of MDSCs that suppress antitumor immunity (Figure 5) (20, 140, 143, 151). The gene discussed is TNFRSF1B; the disease is neoplasm.